- This event has passed.
2016/17 RSAA annual general meeting
September 23, 2017
Guest speaker: James Shaw (Vice-President, Clinical Operations, Neuren Pharmaceuticals)
Topic: Trofinetide: The Journey to Phase III.
Guest speaker: James Shaw (Vice-President, Clinical Operations, Neuren Pharmaceuticals)
Topic: Trofinetide: The Journey to Phase III.